Publisher
Springer Berlin Heidelberg
Reference39 articles.
1. Baldissera RC, Nucci M, Vigorito AC et al (2006) Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk aggressive non-Hodgkin’s lymphoma patients: a prospective randomized GEMOH report. Acta Haematol 115(1–2):15–21
2. Behr TM, Griesinger F, Riggert J, Gratz S, Behe M, Kaufmann CC, Worman B, Brittinger G, Becker W (2002) High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD-20 antibody C2B8 and auotologous stem cell support. Results of a pilot study. Cancer 94(4 Suppl):1363–1372
3. Cilley J, Winter JN (2006) Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas. Haematologica 91(1):114–120
4. Corcoran MC, Eary J, Bernstein I, Press OW (1997) Radioimmunotherapy strategies for non-Hodgkin’s lymphomas. Ann Oncol 8(Suppl):S133–S138
5. Divizzi L, Guidetti A, Tarella C, Mange M, Metteucci P, Seregni E, Chiesa C, Bombardieri E, DiNicola M, Carlo-Stella C, Gianni AM (2008) High-dose Yttrium-90-Ibritumoab Tiuxetan with tandem stem-cell re-infusion: an outpatient preparative regimen for autologous hematopoetic cell transplantation. J Clin Oncol 26:5175–5182